Bentley InnoMed GmbH announced it has been granted two TÜV certificates that extend indications for its stents in complex ...

Healionics Corporation announced that its Stargraft arteriovenous (AV) graft for dialysis access has been granted ...

Simcere Pharmaceuticals Group Ltd. recently announced that findings from the TASTE-2 clinical study have shown that the admini ...

Arsenal Medical announced the initiation of the EMBO-02 clinical study of its NeoCast liquid embolic to treat chronic ...

CVRx, Inc. announced recently that the Centers for Medicare and Medicaid Services (CMS) assigned the company’s Barostim p ...

Xeltis recently announced that the FDA has granted Breakthrough Device designation for the company’s aXess vascular acce ...

November 20, 2024—enVVeno Medical Corporation announced 1-year data on all patients from SAVVE, the United States pivotal trial of the company&r ...

November 11, 2024—iVascular announced the initiation of OPAL, a first-in-human study of Amber, the company’s embolic liquid ...

Solaris Endovascular, Inc. recently announced the formation of the company, which will develop solutions for dialysis access i ...

A female patient in her mid-60s presented to the emergency department with dry gangrene of her left third and fourth digits. She had chronic obstructive pulmonary disease, hypertension, diabetes, and ...

Dr. Singh is a consultant for Cook Medical. All seven of the commercially available abdominal aortic endograft devices perform well when used within the confines of their instructions for use.

This article is a companion to “Coding for Lower Extremity Revascularization in 2011,” which was published in Endovascular Today'sMay 2011 issue. In January 2011, 16 new codes were introduced, ...